Discovering and developing life-changing treatments for patients is our focus. By tailoring biotherapeutic performance using novel protein and gene therapies, we are well-positioned to address unmet medical needs and find treatments for a wide range of diseases and disorders.
Learn More
Highly specialized enzymes can address many challenges faced in DNA and RNA synthesis, NGS, and clinical diagnostics. Whether it’s yield, accuracy, or sample conditions, engineered enzymes can help provide better results.
Learn More
Sustainable bioprocesses enabled by enzymes can eliminate the use of hazardous reagents, remove wasteful steps, and reduce overall manufacturing cost for API production, food ingredients production, and other industrial operations. Explore novel approaches that benefit the triple bottom line – social, environmental, and financial.
A paper authored by Merck and Codexis in the June 2022 issue of the peer-reviewed journal Science, details the development of a suite of enzymes and their application for site-selective synthesis of insulin bioconjugates.
View Paper